![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2005, American Society for Microbiology A Gyrase Mutant with Low Activity Disrupts Supercoiling at the Replication Terminus Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama 35294 *Corresponding author. Mailing address: Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294. Phone: (205) 934-3299. Fax: (205) 975-5955. E-mail: nphiggin/at/uab.edu. Received December 3, 2004; Accepted August 22, 2005. This article has been cited by other articles in PMC.Abstract When a mutation in an essential gene shows a temperature-sensitive phenotype, one usually assumes that the protein is inactive at nonpermissive temperature. DNA gyrase is an essential bacterial enzyme composed of two subunits, GyrA and GyrB. The gyrB652 mutation results from a single base change that substitutes a serine residue for arginine 436 (R436-S) in the GyrB protein. At 42°C, strains with the gyrB652 allele stop DNA replication, and at 37°C, such strains grow but have RecA-dependent SOS induction and show constitutive RecBCD-dependent DNA degradation. Surprisingly, the GyrB652 protein is not inactive at 42°C in vivo or in vitro and it doesn't directly produce breaks in chromosomal DNA. Rather, this mutant has a low kcat compared to wild-type GyrB subunit. With more than twice the normal mean number of supercoil domains, this gyrase hypomorph is prone to fork collapse and topological chaos near the terminus of DNA replication. Temperature-sensitive (TS) mutants have been used to study complex biochemical pathways in prokaryotic and eukaryotic organisms alike. By comparing phenotypes of a TS mutant at permissive and restrictive temperatures, important insights can be obtained about the progression of intermediates through a biochemical pathway. For example, TS mutants guided early studies of DNA replication and provided the initial evidence for three different cellular polymerases (28). TS mutants also showed that replication involves numerous genes, and a large mutant collection guided the in vitro reconstruction of replication initiation and elongation (44, 72). In bacteriophages λ and Mu, TS repressors were found that undergo a change in protein conformation causing repressor-DNA complexes to dissociate at nonpermissive temperatures (24, 31, 69). Physiological studies after shifts from permissive to nonpermissive temperature revealed relevant promoters and important biochemical steps necessary for the onset of the lytic cycle in phage development (19, 30). Thus, it has become expected that when a gene confers a TS phenotype, the cause is a temperature-dependent change in the mutant protein's structure or catalytic activity. DNA gyrase has a unique and essential role in prokaryotic replication and transcription. The enzyme catalyzes the introduction of negative supercoils into covalently closed DNA molecules at the expense of ATP binding and hydrolysis. The enzyme is essential in most prokaryotes and is a critical target for antimicrobial chemotherapy. The quinolone antibiotics are among the most potent antibacterial agents known, and they kill bacteria by turning DNA gyrase (and the closely related enzyme topoisomerase IV [Topo IV]) into a DNA-reactive cytotoxin (23). Gyrase plays at least two essential roles in chromosome structure and function. First, it condenses DNA by converting relaxed DNA molecules into a dynamic, underwound, and plectonemically supercoiled state (12). DNA in living cells is compartmentalized into subchromosomal regions called domains, and the dynamic superhelical structure within a domain affects many processes like transcription, recombination, site-specific recombination, and transposition (12, 18, 33, 36). Second, to unwind the Watson and Crick strands during DNA synthesis, a cell must remove 400,000 positive coils in each chromosome-equivalent of DNA and resolve all catenane links between the replicated chromosomes. Gyrase-driven negative supercoils facilitate both the unwinding and the Topo IV-dependent unlinking of parental strands during bacterial DNA replication (54, 70). We previously described TS mutants of gyrase with an increased number of superhelical domains. At the permissive temperature (30°C), mutations in gyrB were found to cause more than twice as many domains as wild-type (WT) strains over a 100-kb interval spanning the his and cob operons (64, 66). The gyrB652 mutation was originally isolated by Gari et al. (27), and it causes induction of the SOS response at 37°C and shows synthetic lethality in combination with recA or recB mutations. Here, we isolated GyrB652 gyrase and compared it to the WT enzyme. To our surprise, the GyrB652 gyrase was not TS in vitro or in vivo. The enzyme had a low turnover number (kcat) in vitro, and in vivo it caused a dramatic change in supercoil dynamics near the replication terminus. MATERIALS AND METHODS Strains and cloning. Bacterial strains used in this work are listed in Table 1. Both the WT gyrB and the gyrB652 gene from Salmonella enterica serovar Typhimurium were cloned into pET21(a) in Escherichia coli DH5α. Then, plasmids were moved into E. coli BL121::λDE3 (67) for protein expression under control of the phage T7 RNA polymerase. Plasmid pRC06 contains the gyrB gene from WT Salmonella strain LT2, and pRC04 contains the gyrB652 gene with an A-C transversion that changes the Arg 436 codon to Ser.
Enzyme purification. WT and mutant GyrB proteins were expressed and purified using the same protocol. Five milliliters of an overnight culture was used to inoculate 500 ml of Luria broth (LB) containing 50 μg/ml ampicillin. The culture was agitated at 30°C, and cell density was monitored hourly. When the culture reached an optical density at 650 nm of 0.85, IPTG (isopropyl-β-d-thiogalactopyranoside) was added to a final concentration of 0.1 mM, and incubation at 30°C was continued for 2 h. Cultures were chilled to 4°C, and the cells were harvested by centrifugation and resuspended in 60 ml of TGED buffer (50 mM Tris-HCl, pH 8.0, 10% glycerol, 1 mM EDTA, 1 mM dithiothreitol [DTT]). Lysis was induced by addition of 20×-concentrated lysis buffer which made the solution (at final concentration) 2 mM DTT, 20 mM EDTA, 100 mM KCl, 0.2% Brij 58, and 0.4 mg/ml egg white lysozyme. The mixture was placed in centrifugation tubes, incubated at 4°C for 30 min, and centrifuged at 35,000 rpm in a Beckman type 60 Ti ultracentrifuge rotor for 1 h at 4°C. Solid streptomycin sulfate was added to the supernatant at a final concentration of 4%, and the mixture was stirred at 4°C for 30 min. After centrifugation for 30 min in a Beckman J21 rotor at 7,000 rpm, solid ammonium sulfate was added to the supernatant at a final concentration of 50% saturation. After centrifugation in a Beckman J21 rotor at 7,000 rpm, the pellet was dissolved in 1× TGED buffer with 1 M NaCl. Dialysis was carried out overnight in TGED with 1 M NaCl. Novobiocin was covalently coupled to CNBr-activated Sepharose 4B according to instructions supplied by Amersham Biotech. Ten milliliters of a dialyzed protein solution was applied to a 5-ml (bed volume) novobiocin-agarose column, and the applied protein solution was recirculated through on the column for 1 h. Washing with 15 ml of solution containing 2 M urea in 1× TGED eluted most of the protein bound to the resin. GyrB protein was then eluted in 6 M guanidine-HCl in 1× TGED. Fractions with the highest protein concentration were identified by Bio-Rad protein assays and dialyzed for 12 h against 1× TGED at a maximum protein concentration of 1 mg/ml, which allowed the refolding of the purified GyrB protein. The dialyzed solution was clarified by centrifugation, and the supernatant was assayed for supercoiling activity after addition of GyrA protein. Renatured GyrB protein was applied to a 5-ml DEAE column equilibrated with 1× TGED buffer. Active GyrB protein eluted in a 100-ml TGED gradient that varied linearly from 0 to 0.5 M NaCl. Fractions with the highest specific activity were identified using GyrA-complemented DNA supercoiling assays (35). Active fractions were pooled and applied to a 200-ml Sephacryl S-200 column equilibrated in 0.2 M KPO4, pH 7.4, 10% glycerol, 1 mM EDTA, and 5 mM DTT. Sephacryl fractions (20 ml) near the void volume were assayed and concentrated by dialysis into 50% glycerol containing 10 mM Tris-HCl, pH 7.4, 50 mM KPO4, 1 mM DTT, and 0.1 mM EDTA, which reduced the volume by half. Both the WT and GyrB652 subunits were stable at −20°C in this buffer. Genetic methods. PCR products were “sewn” into a 9-kb module containing a complete WT Lac operon (lacIZYA), the gentamicin resistance gene aacC1 [aminoglycoside-(3)-N-acetyltransferase] from Tn1696 flanked by a pair of res sites, and a pair of FLP recognition target (FRT) sites. The PCR product of the 9-kb module was cloned into plasmid pCR-XL-TOPO (Invitrogen) between nucleotides 336 and 337, generating the plasmid pPM1 (sequence available on request). To introduce a Lac-Gen-res module into a chromosome, a FRT site was first inserted into a specific location in the Salmonella chromosome using techniques and reagents described by Datsenko and Wanner (14). Strains containing a single chromosomal FRT site and the pCP20 plasmid, which expresses FLP recombinase at 42°C, were grown to late log phase at 30°C and incubated at 42°C for 10 min to induce FLP expression. After chilling in ice water, cells were made competent by 30 s of centrifugation and resuspension in ice-cold water and were electroporated with plasmid pPM1. FLP recombinase catalyzes the excision of a FRT circle from pPM1 and its reintegration into the chromosomal FRT site. Each culture was infected with P22 at low multiplicity and incubated at 30°C in a shaking incubator until cell lysis (37). Strains NH3514 (LT2/pJBREScI) or NH3515 (gyrB652/pJBREScI) were transduced with the resulting P22 phage to generate strains NH3504 to -3511. Gentamicin-resistant transductants that stained blue on X-Gal (5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside) plates and were Kan sensitive were subsequently tested for the correct location of the Lac operon using primers in the bacterial chromosome and in the Lac-Gen-res module. RESULTS The GyrB652 protein is not TS for supercoiling. Gari et al. isolated the Salmonella gyrB652 mutant and reported it to be constitutively induced for SOS functions and to show RecBCD-dependent DNA degradation (27). To examine the biochemical properties of this mutant, we purified Salmonella WT GyrB and GyrB652 proteins (see Materials and Methods). When mixed with either E. coli or Salmonella GyrA protein, the specific activity of WT S. enterica serovar Typhimurium GyrB-containing gyrase was comparable to purified WT E. coli gyrase— at 105 U/mg of purified protein. The specific activity of gyrase reconstituted with the Salmonella GyrB652 protein was 1/3 to 1/5 that of the WT protein reconstituted with either E. coli or Salmonella GyrA. Gyrase containing the WT Salmonella GyrB or the GyrB652 protein was tested in supercoiling assays at three temperatures—30°C, which is permissive for growth; 37°C, which shows an SOS phenotype for GyrB652; and 42°C, which is nonpermissive for GyrB652. Supercoiling assays are not linear with respect to added enzyme because DNA intermediates become distributed in a family of bands with electrophoretic mobility between relaxed and fully supercoiled positions. A unit of gyrase has been defined by an endpoint dilution assay in which 1 unit of enzyme supercoils 0.2 μg of relaxed plasmid DNA to a highly supercoiled band after 30 min at 30°C, as measured by gel electrophoresis in an agarose gel lacking an intercalator (35). The activities of different gyrase preparations were compared using either 1 U or 4 U of mutant or WT enzyme incubated for half the normal time (15 min). Gyrase made with the WT GyrB subunit completely supercoiled the relaxed plasmid in 15 min at 30°C (Fig. (Fig.1A,1A
Supercoiling reactions in vitro might differ from in vivo reactions in critical ways. For example, at the restrictive temperature in vivo a mutant enzyme could be refolded by molecular chaperones or degraded by cellular proteases. Thus, the in vivo supercoiling phenotype for a TS GyrB652 strain might not be apparent in vitro. To test gyrase activity in vivo, the supercoil density of the plasmid pUC19 was measured at permissive and nonpermissive temperatures. Plasmid supercoiling is exquisitely sensitive to change in gyrase activity (32, 46, 57). For example, inhibition of gyrase with novobiocin or a fluoroquinolone leads to a loss in plasmid linking number within minutes of drug addition (53, 75). To test in vivo supercoiling, a WT and a GyrB652 mutant strain was grown to mid-log phase (optical density at 65 nm, 0.6) at 30°C. A portion of each culture was shifted to 42°C and incubated for 1 h. Plasmid DNA was purified from both the 30°C and 42°C cultures, and aliquots of plasmid DNA were loaded onto an agarose gel containing 25 μM chloroquine phosphate, which partially unwinds DNA to reveal the distribution of topoisomers. For Salmonella strain NH2585 (WT), the average superhelical density of plasmids isolated from cells held at 30°C was similar to plasmids from cells incubated at 42°C (Fig. (Fig.1B,1B The GyrB652 subunit has low catalytic activity. The in vitro and in vivo supercoiling results (Fig. (Fig.1)1 To test the hypothesis, an assay was required that is not biased by the possible presence of inactive enzyme. Supercoiling assays do not distinguish between slow and partially inactive proteins because the reaction is somewhat distributive. Measuring a supercoil rate per enzyme molecule requires knowing the number of active enzymes, but cleavage assays meet the requirement. A high-affinity binding site for gyrase in bacteriophage Mu (the strong gyrase site [SGS]) is bound and cleaved efficiently after addition of fluoroquinolones in vitro and in vivo (50, 60). The SGS is highly preferred as a gyrase binding site, and only one gyrase tetramer can bind to the SGS. During strand transfer the complex passes through a covalent intermediate wherein the DNA backbone is linked to tyrosine-122 of the GyrA subunit (11, 43). In the absence of drugs, covalent gyrase-DNA complexes are a fleeting species because biochemical equilibrium strongly favors a noncovalent form of enzyme-bound DNA (34). Enoxacin shifts the equilibrium so that gyrase makes an efficient double-strand break following the addition of denaturing agents like sodium dodecyl sulfate (SDS) (60). Because gyrase does not turn over in cleavage assays, DNA breakage of preformed gyrase-DNA complexes monitors only the active protein bound to a single site on DNA. To measure the transition from a bound but uncleaved complex to cleavage complex, WT GyrB- and GyrB652-reconstituted gyrase was incubated for an hour with plasmid pMP1000, which has a 1-kb fragment with the Mu SGS cloned into a pBR322-derived plasmid (50). Digestion with EcoRI generates a 3.69-kb linear molecule, but after gyrase cleavage at the SGS, two bands appear: a 2.78-kb fragment and a small rapidly migrating 0.91-kb band (not seen in Fig. Fig.2).2
DNA cleavage was slower for GyrB652 gyrase than for the WT gyrase (Fig. 2B, C, and D Strains with the gyrB652 allele lose supercoil dynamics near the dif site. If gyrase is active at 42°C, why does a GyrB652 strain stop growth and DNA synthesis at 42°C rather than just slowing down? The terminus of replication has unique topological roles in bacterial chromosome replication and segregation. Bidirectional DNA synthesis in both E. coli and Salmonella leads the two forks that initiate replication at oriC to converge on the terminus. Twin domains of supercoiling predict that the terminus could experience a loss of negative supercoiling or might even become positively supercoiled during fork convergence (25, 73). In addition, dimeric chromosomes that arise from reciprocal recombination must be resolved to monomers by site-specific recombination at dif prior to cell division (45, 52). To study supercoiling at dif, transposons with associated res sites were isolated near dif. The resolvase system uses movement of plectonemic negative supercoils to form a recombination synapse—a three-node superhelix that pairs two 120-bp resolution sites (res sites) (65). Resolution reactions were studied at three different locations, the his-cob interval, which is 468 kb from dif (37), an interval within 3 kb of the dif site, and a third interval in the opposite replichore 600 kb from dif near moeA (Table 1 and Fig. Fig.3A).3A
However, gyrB652 derivatives had a markedly different profile (Fig. (Fig.3B).3B
Resolution assays at three chromosomal locations showed differences in supercoiling caused by the GyrB652 mutant. These assays monitor the loss of the MudJr2 element, which includes a lacZ gene and a Kan resistance gene. However, each interval is slightly different in size and there might be supercoil influences associated with the bacterial genes altered by transposon insertions or caused by the resulting deletion. To eliminate these complications, a copy of the complete E. coli lac operon, flanked by directly repeated res sites, was introduced into four intergenic locations of the Salmonella chromosome (Fig. (Fig.4;4
DISCUSSION Gyrase formed with the GyrB652 subunit is not a TS enzyme in vitro or in vivo (Fig. (Fig.11 Since the TS response is not a failure of the enzyme to work at 42°C, why do cells stop growth? As a central enzyme in DNA metabolism, the catalytic rate of gyrase could be required to operate within specific limits to accommodate DNA compaction and cell division timing mechanisms. We suggest that three factors could contribute to replication problems in gyrB hypomorphic mutants. First, even at permissive temperature (30°C) the number of supercoil domains per genome equivalent of DNA in a GyrB652 strain increases to over 1,000 from the 400 domains found in WT cells (17, 55, 66). Although our assay restricts us to studies at 30°C because of the TS repressor control on resolvase expression, others have shown that the number of DNA genome equivalents per cell at the fastest growth rates reaches a median between 2 and 4 (62). Under these conditions, unless gyrase expression increases, domains will exceed the number of cellular gyrase molecules (about 1,000/cell) by severalfold. Second, during chromosomal replication, oriC is physically separated from the terminus during formation of sister nucleoids (5, 20, 49, 68). Work from several labs shows that the physical separation of ori and the terminus is a highly reproducible part of a bacterial cell cycle (5, 20, 71). Third, the chromosomes in GyrB652 cells show a gradient of supercoil disruption in which the region closest to oriC is nearest to normal WT and the dif region is the most disorganized (Fig. 3B to C Another factor may involve Topo IV (a tetramer of ParC and ParE proteins), which relaxes both positive and negative supercoils in addition to decatenating the replicated sister chromosomes (13, 16, 22). Topo IV contributes to the supercoil balance in vivo (75), and it becomes concentrated near the terminus of replication (21), possibly occupying a high-affinity site near dif (38). Topo IV relaxation activity near dif would exacerbate the loss of gyrase-dependent supercoiling in a GyrB652 mutant. Dichotomous chaos and the terminus. In addition to discovering the complex GyrB652 phenotype, Gari et al. found that cell growth is required for gyrase mutants to trigger an SOS response (26). A genetic selection for cells that survive recA- or recBCD-gyrA208 synthetic lethality revealed TS mutants in tRNA aminoacyl synthetases. When protein synthesis was blocked soon after temperature up-shift, cells were protected from synthetic lethality and SOS induction. Garil et al. (26) proposed that chromosome breaks were caused by unbalanced growth and suggested a link to thymine-less death that occurs in both prokaryotes and eukaryotes (3). We propose that the factors listed above contribute to unbalanced growth during dichotomous growth, which is the poly-fork DNA replication pattern that accompanies growth of E. coli and Salmonella in rich medium at a high temperature (Fig. 5A to C
All barriers to the DnaB helicase must be eliminated to allow unimpeded fork movement at the normal rate of >800 bp/s. We hypothesize that DNA replication in cells carrying the sluggish hypomorphic gyrase bogs down due to poor supercoil condensation of DNA near the terminus. If a fork collapses while cell growth continues (10, 47), there is a critical time for restarting before new forks overtake the stalled fork (Fig. (Fig.5).5 The terminal chaos hypothesis is consistent with several recent observations. In an E. coli gyrase hypomorph, Jeong et al. found a large disruption in gene expression near dif, and their chromosome immunoprecipitation assays indicated gyrase depletion near the terminus (41). Moreover, several genetic conditions that increase oriC initiation also trigger fork failure. One example is the overproduction of DnaA, which leads to overinitiation, fork collapse (29), and breakage of chromosomal DNA with loss of cell viability (61). Terminal chaos can explain the sickness of SeqA mutants, which must be grown in minimal medium at a low temperature because they lack the mechanism by which SeqA inhibits premature reinitiation by blocking access of DnaA protein to oriC (9, 63). In addition to gyrase, SeqA, and DnaA, phenotypes of growth rate toxicity are found with mutants of priA (58, 59), mukB (1), diaA (40), and parC and parE (2). If resolution near dif is specifically impaired in several of these mutants, then defining a comprehensive set of genes that change domain structure at high growth rates would be an important step toward completing our understanding of DNA fork termination and chromosome segregation. Acknowledgments This work was supported by National Institutes of Health grant GM-33143-20 and MCB 0110675 from the National Science Foundation. We thank N. Bossi, N. Figueroa, and M. Schmid for the gift of mutant strains. REFERENCES 1. Adachi, S., and S. Hiraga. 2003. Mutants suppressing novobiocin hypersensitivity of a mukB null mutation. J. Bacteriol. 185:3690-3695. [PubMed] 2. Adams, D. E., E. M. Shekhtman, E. L. Zechiedrich, M. B. Schmid, and N. R. Cozzarelli. 1992. The role of topoisomerase IV in partitioning bacterial replicons and the structure of catenated intermediates in DNA replication. Cell 71:277-288. [PubMed] 3. Ahmad, S. I., S. H. Kirk, and A. Eisenstark. 1998. Thymine metabolism and thymineless death in prokaryotes and eukaryotes. Rev. Microbiol. 52:591-625. 4. Bakhlanova, I. V., T. Ogawa, and V. A. Lanzov. 2001. Recombinogenic activity of chimeric recA genes (Pseudomonas aeruginosa/Escherichia coli): a search for RecA protein regions responsible for this activity. Genetics 159:7-15. [PubMed] 5. Bates, D., and N. Kleckner. 2005. Chromosome and replisome dynamics in E. coli: loss of sister cohesion triggers global chromosome movement and mediates chromosome segregation. Cell 121:899-911. [PubMed] 6. Bidnenko, V., S. D. Ehrlich, and B. Michel. 2002. Replication fork collapse at replication terminator sequences. EMBO J. 21:3898-3907. [PubMed] 7. Breier, A. M., H.-U. G. Weier, and N. R. Cozzarelli. 2005. Independence of replisomes in Escherichia coli chromosomal replication. Proc. Natl. Acad. Sci. USA 102:3942-3947. [PubMed] 8. Cabral, J. H. M., A. P. Jackson, C. V. Smith, N. Shikotra, A. Maxwell, and R. C. Siddington. 1997. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 388:903. [PubMed] 9. Campbell, J. L., and N. Kleckner. 1990. E. coli oriC and the dnaA gene promoter are sequestered from dam methyltransferase following the passage of the chromosomal replication fork. Cell 62:967-979. [PubMed] 10. Cox, M. M., M. F. Goodman, K. N. Kreuzer, D. J. Sherratt, S. J. Sandler, and K. J. Marians. 2000. The importance of repairing stalled replication forks. Nature 404:37-41. [PubMed] 11. Cozzarelli, N. R. 1980. DNA gyrase and the supercoiling of DNA. Science 207:953-960. [PubMed] 12. Cozzarelli, N. R., and J. C. Wang. 1990. DNA topology and its biological effects. Cold Spring Harbor Press, Cold Spring Harbor, N.Y. 13. Crisona, N. J., T. R. Strick, D. Bensimon, V. Croquette, and N. R. Cozzarelli. 2000. Preferential relaxation of positively supercoiled DNA by Escherichia coli topoisomerase IV in single-molecule and ensemble measurements. Genes Dev. 14:2881-2892. [PubMed] 14. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using polymerase chain reaction products. Proc. Natl. Acad. Sci. USA 97:6640-6645. [PubMed] 15. Davenport, R. J., J. L. Wuite, R. Landick, and C. Bustamante. 2000. Single-molecule study of transcriptional pausing and arrest by E. coli RNA polymerase. Science 287:2497-2500. [PubMed] 16. Deibler, R. W., S. Rahmati, and E. L. Zechiedrich. 2001. Topoisomerase IV, alone, unknots DNA in E. coli. Genes Dev. 15:748-761. [PubMed] 17. Deng, S., R. A. Stein, and N. P. Higgins. Submitted for publication. 18. Deng, S., R. A. Stein, and N. P. Higgins. 2004. Transcription-induced barriers to supercoil diffusion in the Salmonella typhimurium chromosome. Proc. Natl. Acad. Sci. USA 101:3398-3403. [PubMed] 19. Echols, H., and G. Guarneros. 1983. Control of integration and excision, p. 75-92. In R. W. Hendrix, J. W. Roberts, F. W. Stahl, and R. A. Weisberg (ed.), Lambda II. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 20. Elmore, S., M. Muller, N. Vischer, T. Odijk, and C. Woldringh. 2005. Single-particle tracking of oriC-GFP fluorescent spots during chromosome segregation in Escherichia coli. J. Struct. Biol. 136:53-66. 21. Espeli, O., C. Levine, H. Hassing, and K. J. Marians. 2003. Temporal regulation of topoisomerase IV activity in E. coli. Mol. Cell 11:189-201. [PubMed] 22. Espeli, O., and K. J. Marians. 2004. Untangling intracellular DNA topology. Mol. Microbiol. 52:925-931. [PubMed] 23. Froelich-Ammon, S. J., and N. Osheroff. 1995. Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J. Biol. Chem. 270:21429-21432. [PubMed] 24. Gaitanaris, G. A., A. G. Papavassiliou, P. Rubock, S. J. Silverstein, and M. E. Gottesman. 1990. Renaturation of denatured l repressor requires heat shock proteins. Cell 61:1013-1020. [PubMed] 25. Gamper, H. B., and J. E. Hearst. 1982. A topological model for transcription based on unwinding angle analysis of E. coli RNA polymerase binary, initiation and ternary complexes. Cell 29:81-90. [PubMed] 26. Gari, E., L. Bossi, and N. Figueroa-Bossi. 2001. Growth-dependent DNA breakage and cell death in a gyrase mutant of Salmonella. Genetics 159:1405-1414. [PubMed] 27. Gari, E., N. Figueroa-Bossi, A.-B. Blanc-Potard, F. Spirito, M. B. Schmid, and L. Bossi. 1996. A class of gyrase mutants of Salmonella typhimurium show quinolone-like lethality and require Rec functions for viability. Mol. Microbiol. 21:111-122. [PubMed] 28. Gefter, M. L., Y. Hirota, T. Kornberg, J. A. Wechsler, and C. Barnoux. 1971. Analysis of DNA polymerases II and 3 in mutants of Escherichia coli thermosensitive for DNA synthesis. Proc. Natl. Acad. Sci. USA 68:3150-3153. [PubMed] 29. Grigorian, A. V., R. B. Lustig, E. C. Guzman, J. M. Mahaffy, and J. W. Zyskind. 2003. Escherichia coli cells with increased levels of DnaA and deficient in recombinational repair have decreased viability. J. Bacteriol. 185:630-644. [PubMed] 30. Gussin, G. N., A. D. Johnson, C. O. Pabo, and R. T. Sauer. 1983. Repressor and cro protein: structure, function and role in lysogenization, p. 93-121. In R. W. Hendrix, J. W. Roberts, F. W. Stahl, and R. A. Weisberg (ed.), Lambda II. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 31. Hecht, M. H., H. C. M. Nelson, and R. T. Sauer. 1983. Mutations in lambda repressor's amino-terminal domain: implications for protein stability and DNA binding. Proc. Natl. Acad. Sci. USA 80:2676-2680. [PubMed] 32. Higgins, C. F., C. J. Dorman, D. A. Stirling, L. Waddell, I. R. Booth, G. May, and E. Bremer. 1988. A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhimurium and E. coli. Cell 52:569-584. [PubMed] 33. Higgins, N. P. 1999. DNA supercoiling and its consequences for chromosome structure and function, p. 189-202. In R. L. Charlebois (ed.), Organization of the prokaryotic genome, vol. 1. ASM Press, Washington, D.C. 34. Higgins, N. P., and N. R. Cozzarelli. 1982. The binding of gyrase to DNA: analysis by retention to nitrocellulose filters. Nucleic Acids Res. 10:6833-6847. [PubMed] 35. Higgins, N. P., C. L. Peebles, A. Sugino, and N. R. Cozzarelli. 1978. Purification of the subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity. Proc. Natl. Acad. Sci. USA 75:1773-1777. [PubMed] 36. Higgins, N. P., and A. Vologodskii. 2004. Topological behavior of plasmid DNA, p. 181-201. In G. Phillips and B. Funnell (ed.), Plasmid biology. ASM Press, Washington, D.C. 37. Higgins, N. P., X. Yang, Q. Fu, and J. R. Roth. 1996. Surveying a supercoil domain by using the γδ resolution system in Salmonella typhimurium. J. Bacteriol. 178:2825-2835. [PubMed] 38. Hojgaard, A., H. Szerlong, C. Tabor, and P. Kuempel. 1999. Norfloxacin-induced DNA cleavage occurs at the dif resolvase locus in Escherichia coli and is the result of interaction with topoisomerase IV. Mol. Microbiol. 33:1027-1036. [PubMed] 39. Hooper, D. C. 1993. Quinolone mode of action—new aspects. Drugs 45:8-14. [PubMed] 40. Ishida, T., N. Akimitsu, T. Kashioka, M. Hatano, T. Kubota, Y. Ogata, K. Sekimizu, and T. Katayama. 2004. DiaA, a novel DnaA-binding protein, ensures the timely initiation of Escherichia coli chromosome replication. J. Biol. Chem. 279:45546-45555. [PubMed] 41. Jeong, K. S., J. Ahn, and A. B. Khodursky. 2004. Spatial patterns of transcriptional activity in the chromosome of Escherichia coli. Genome Biol. 5:R86. [PubMed] 42. Kampranis, S. C., A. D. Bates, and A. Maxwell. 1999. A model for the mechanism of strand passage by DNA gyrase. Proc. Natl. Acad. Sci. USA 96:8414-8419. [PubMed] 43. Kampranis, S. C., and A. Maxwell. 1998. The DNA gyrase-quinolone complex. ATP hydrolysis and the mechanism of DNA cleavage. J. Biol. Chem. 273:22615-22626. [PubMed] 44. Kornberg, A., and T. Baker. 1991. DNA replication, 2nd ed. W. H. Freeman & Co., New York, N.Y. 45. Louarn, J. M., P. Kuempel, and F. Cronet. 2005. The terminus region of the E. coli chromosome or all's well that ends well, p. 251-273. In N. P. Higgins (ed.), The bacterial chromosome. ASM Press, Washington, D.C. 46. Menzel, R., and M. Gellert. 1983. Regulation of the genes for E. coli DNA gyrase: homeostatic control of DNA supercoiling. Cell 34:105-113. [PubMed] 47. Michel, B., G. Grompone, M.-J. Flores, and V. Bidnenko. 2004. Multiple pathways process stalled replication forks. Proc. Natl. Acad. Sci. USA 101:12783-12788. [PubMed] 48. Miller, W. G., and R. W. Simons. 1993. Chromosomal supercoiling in Escherichia coli. Mol. Microbiol. 10:675-684. [PubMed] 49. Niki, H., Y. Yamaichi, and S. Hiraga. 2000. Dynamic organization of chromosomal DNA in Escherichia coli. Genes Dev. 14:212-223. [PubMed] 50. Pato, M., and M. Banerjee. 1996. The Mu strong gyrase-binding site promotes efficient synapsis of the prophage termini. Mol. Microbiol. 22:283-292. [PubMed] 51. Pavitt, G. D., and C. F. Higgins. 1993. Chromosomal domains of supercoiling in Salmonella typhimurium. Mol. Microbiol. 10:685-696. [PubMed] 52. Perals, K., F. Cornet, Y. Merlet, and J.-M. Louarn. 2000. Functional polarization of the Escherichia coli chromosome terminus. The dif site acts in chromosome dimer resolution only when located between long stretches of opposite polarities. Mol. Microbiol. 36:33-43. [PubMed] 53. Peter, B. J., J. Arsuaga, A. M. Breier, A. B. Khodursky, P. O. Brown, and N. R. Cozzarelli. 2004. Genomic transcriptional response to loss of chromosomal supercoiling in Escherichia coli. Genome Biol. 5:R87. [PubMed] 54. Postow, L., N. J. Crisona, B. J. Peter, C. D. Hardy, and N. R. Cozzarelli. 2001. Topological challenges to DNA replication: conformations at the fork. Proc. Natl. Acad. Sci. USA 98:8219-8226. [PubMed] 55. Postow, L., C. D. Hardy, J. Arsuaga, and N. R. Cozzarelli. 2004. Topological domain structure of the Escherichia coli chromosome. Genes Dev. 18:1766-1779. [PubMed] 56. Reece, R., and A. Maxwell. 1991. DNA gyrase: structure and function. Crit. Rev. Biochem. Mol. Biol. 26:335-375. [PubMed] 57. Richardson, S. M. H., C. F. Higgins, and D. M. J. Lilley. 1984. The genetic control of DNA supercoiling in Salmonella typhimurium. EMBO J. 3:1745-1752. [PubMed] 58. Sandler, S. 1996. Overlapping functions for recF and priA in cell viability and UV-inducible SOS expression are distinguished by dnaC809 in Escherichia coli K-12. Mol. Microbiol. 19:871-880. [PubMed] 59. Sandler, S., H. Samra, and A. Clark. 1996. Differential suppression of priA2::kan phenotypes in Escherichia coli K-12 by mutations in priA, lexA, and dnaC. Genetics 143:5-13. [PubMed] 60. Scheirer, K. E., and N. P. Higgins. 1997. The DNA cleavage reaction of DNA gyrase. Comparison of stable ternary complexes formed with enoxacin and CcdB protein. J. Biol. Chem. 272:27202-27209. [PubMed] 61. Simmons, L. A., A. M. Breier, N. R. Cozzarelli, and J. M. Kaguni. 2004. Hyperinitiation of DNA replication in Escherichia coli leads to replication fork collapse and inviability. Mol. Microbiol. 51:349-358. [PubMed] 62. Skarstad, K., R. Bernander, and E. Boye. 1995. Analysis of DNA replication in vivo by flow cytometry. Methods Enzymol. 262:604-613. [PubMed] 63. Skarstad, K., N. Torheim, S. Wold, R. Lurz, W. Messer, S. Fossum, and T. Bach. 2001. The Escherichia coli SeqA protein binds specifically to two sites in fully and hemimethylated oriC and has the capacity to inhibit DNA replication and affect chromosome topology. Biochimie 83:49-51. [PubMed] 64. Staczek, P., and N. P. Higgins. 1998. DNA gyrase and topoisomerase IV modulate chromosome domain size in vivo. Mol. Microbiol. 29:1435-1448. [PubMed] 65. Stark, M. W., and M. R. Boocock. 1995. Topological selectivity in site-specific recombination, p. 179. In D. Sherratt (ed.), Mobile genetic elements, vol. 58. IRL Press, Oxford, England. 66. Stein, R., S. Deng, and N. P. Higgins. 2005. Measuring chromosome dynamics on different timescales using resolvases with varying half-lives. Mol. Microbiol. 56:1049-1061. [PubMed] 67. Studier, F. W. 1991. Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system. J. Mol. Biol. 219:37-44. [PubMed] 68. Sunako, Y., T. Onogi, and S. Hiraga. 2001. Sister chromosome cohesion of Escherichia coli. Mol. Microbiol. 42:1233-1241. [PubMed] 69. Vogel, J. L., Z. J. Li, M. M. Howe, A. Toussaint, and N. P. Higgins. 1991. Temperature-sensitive mutations in the bacteriophage Mu c repressor locate a 63-amino-acid DNA-binding domain. J. Bacteriol. 173:6568-6577. [PubMed] 70. Vologodskii, A. V., W. Zhang, V. V. Rybenkov, A. A. Podtelezhnikov, D. Subramanian, J. D. Griffith, and N. R. Cozzarelli. 2001. Mechanism of topology simplification by type II DNA topoisomerases. Proc. Natl. Acad. Sci. USA 98:3045-3049. [PubMed] 71. Wang, X., C. Possoz, and D. J. Sherratt. 2005. Dancing around the divisome: asymmetric chromosome segregation in Escherichia coli. Genes Dev. 19:2367-2377. [PubMed] 72. Wechsler, J. A., V. Nusslein, B. Otto, A. Klein, F. Bonhoeffer, R. Herrmann, L. Gloger, and H. Schaller. 1973. Isolation and characterization of thermosensitive Escherichia coli mutants defective in deoxyribonucleic acid replication. J. Bacteriol. 113:1381-1388. [PubMed] 73. Wu, H.-Y., S. Shyy, J. C. Wang, and L. F. Liu. 1988. Transcription generates positively and negatively supercoiled domains in the template. Cell 53:433-440. [PubMed] 74. Yu, D., J. A. Sawitzke, H. Ellis, and D. L. Court. 2003. Recombineering with overlapping single-stranded DNA oligonucleotides: testing a recombination intermediate. Proc. Natl. Acad. Sci. USA 100:7099-7104. [PubMed] 75. Zechiedrich, E. L., B. K. Arkady, S. Bachellier, D. Chen, D. M. Lilley, and N. R. Cozzarelli. 2000. Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli. J. Biol. Chem. 275:8103-8113. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Proc Natl Acad Sci U S A. 1971 Dec; 68(12):3150-3.
[Proc Natl Acad Sci U S A. 1971]J Bacteriol. 1973 Mar; 113(3):1381-8.
[J Bacteriol. 1973]Cell. 1990 Jun 15; 61(6):1013-20.
[Cell. 1990]Proc Natl Acad Sci U S A. 1983 May; 80(9):2676-80.
[Proc Natl Acad Sci U S A. 1983]J Bacteriol. 1991 Oct; 173(20):6568-77.
[J Bacteriol. 1991]J Biol Chem. 1995 Sep 15; 270(37):21429-32.
[J Biol Chem. 1995]Proc Natl Acad Sci U S A. 2004 Mar 9; 101(10):3398-403.
[Proc Natl Acad Sci U S A. 2004]Proc Natl Acad Sci U S A. 2001 Jul 17; 98(15):8219-26.
[Proc Natl Acad Sci U S A. 2001]Proc Natl Acad Sci U S A. 2001 Mar 13; 98(6):3045-9.
[Proc Natl Acad Sci U S A. 2001]Mol Microbiol. 1998 Sep; 29(6):1435-48.
[Mol Microbiol. 1998]Mol Microbiol. 2005 May; 56(4):1049-61.
[Mol Microbiol. 2005]Mol Microbiol. 1996 Jul; 21(1):111-22.
[Mol Microbiol. 1996]J Mol Biol. 1991 May 5; 219(1):37-44.
[J Mol Biol. 1991]Proc Natl Acad Sci U S A. 1978 Apr; 75(4):1773-7.
[Proc Natl Acad Sci U S A. 1978]Proc Natl Acad Sci U S A. 2000 Jun 6; 97(12):6640-5.
[Proc Natl Acad Sci U S A. 2000]J Bacteriol. 1996 May; 178(10):2825-35.
[J Bacteriol. 1996]Mol Microbiol. 1996 Jul; 21(1):111-22.
[Mol Microbiol. 1996]Proc Natl Acad Sci U S A. 1978 Apr; 75(4):1773-7.
[Proc Natl Acad Sci U S A. 1978]Cell. 1988 Feb 26; 52(4):569-84.
[Cell. 1988]Cell. 1983 Aug; 34(1):105-13.
[Cell. 1983]EMBO J. 1984 Aug; 3(8):1745-52.
[EMBO J. 1984]Genome Biol. 2004; 5(11):R87.
[Genome Biol. 2004]J Biol Chem. 2000 Mar 17; 275(11):8103-13.
[J Biol Chem. 2000]Genetics. 2001 Dec; 159(4):1405-14.
[Genetics. 2001]Mol Microbiol. 1996 Jul; 21(1):111-22.
[Mol Microbiol. 1996]Mol Microbiol. 1996 Oct; 22(2):283-92.
[Mol Microbiol. 1996]J Biol Chem. 1997 Oct 24; 272(43):27202-9.
[J Biol Chem. 1997]Science. 1980 Feb 29; 207(4434):953-60.
[Science. 1980]J Biol Chem. 1998 Aug 28; 273(35):22615-26.
[J Biol Chem. 1998]Nucleic Acids Res. 1982 Nov 11; 10(21):6833-47.
[Nucleic Acids Res. 1982]Mol Microbiol. 1996 Oct; 22(2):283-92.
[Mol Microbiol. 1996]Cell. 1982 May; 29(1):81-90.
[Cell. 1982]Cell. 1988 May 6; 53(3):433-40.
[Cell. 1988]Mol Microbiol. 2000 Apr; 36(1):33-43.
[Mol Microbiol. 2000]J Bacteriol. 1996 May; 178(10):2825-35.
[J Bacteriol. 1996]Mol Microbiol. 1993 Nov; 10(3):675-84.
[Mol Microbiol. 1993]Mol Microbiol. 1993 Nov; 10(3):685-96.
[Mol Microbiol. 1993]Nature. 1997 Aug 28; 388(6645):903-6.
[Nature. 1997]Proc Natl Acad Sci U S A. 1999 Jul 20; 96(15):8414-9.
[Proc Natl Acad Sci U S A. 1999]Crit Rev Biochem Mol Biol. 1991; 26(3-4):335-75.
[Crit Rev Biochem Mol Biol. 1991]Science. 2000 Mar 31; 287(5462):2497-500.
[Science. 2000]Genetics. 2001 Sep; 159(1):7-15.
[Genetics. 2001]Genes Dev. 2004 Jul 15; 18(14):1766-79.
[Genes Dev. 2004]Mol Microbiol. 2005 May; 56(4):1049-61.
[Mol Microbiol. 2005]Methods Enzymol. 1995; 262():604-13.
[Methods Enzymol. 1995]Cell. 2005 Jun 17; 121(6):899-911.
[Cell. 2005]Genes Dev. 2000 Jan 15; 14(2):212-23.
[Genes Dev. 2000]Genes Dev. 2000 Nov 15; 14(22):2881-92.
[Genes Dev. 2000]Genes Dev. 2001 Mar 15; 15(6):748-61.
[Genes Dev. 2001]Mol Microbiol. 2004 May; 52(4):925-31.
[Mol Microbiol. 2004]J Biol Chem. 2000 Mar 17; 275(11):8103-13.
[J Biol Chem. 2000]Mol Cell. 2003 Jan; 11(1):189-201.
[Mol Cell. 2003]Genetics. 2001 Dec; 159(4):1405-14.
[Genetics. 2001]Proc Natl Acad Sci U S A. 2005 Mar 15; 102(11):3942-7.
[Proc Natl Acad Sci U S A. 2005]Nature. 2000 Mar 2; 404(6773):37-41.
[Nature. 2000]Proc Natl Acad Sci U S A. 2004 Aug 31; 101(35):12783-8.
[Proc Natl Acad Sci U S A. 2004]EMBO J. 2002 Jul 15; 21(14):3898-907.
[EMBO J. 2002]Drugs. 1993; 45 Suppl 3():8-14.
[Drugs. 1993]Genome Biol. 2004; 5(11):R86.
[Genome Biol. 2004]J Bacteriol. 2003 Jan; 185(2):630-44.
[J Bacteriol. 2003]Mol Microbiol. 2004 Jan; 51(2):349-58.
[Mol Microbiol. 2004]Cell. 1990 Sep 7; 62(5):967-79.
[Cell. 1990]Biochimie. 2001 Jan; 83(1):49-51.
[Biochimie. 2001]Proc Natl Acad Sci U S A. 2000 Jun 6; 97(12):6640-5.
[Proc Natl Acad Sci U S A. 2000]Proc Natl Acad Sci U S A. 2003 Jun 10; 100(12):7099-104.
[Proc Natl Acad Sci U S A. 2003]J Bacteriol. 1996 May; 178(10):2825-35.
[J Bacteriol. 1996]Mol Microbiol. 1998 Sep; 29(6):1435-48.
[Mol Microbiol. 1998]